Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Melrose Laboratories Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (50)
ARTG (31)
Cancellation or suspension (3)
Listed medicine compliance report (1)

Date

2024 (16)
2023 (7)
2022 (13)
2021 (6)
2020 (1)
2019 (7)
2018 (16)
2017 (11)
2016 (1)
2015 (3)
1994 (1)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

85 result(s) found, displaying 61 to 70

Natural Ultra Strength Astaxanthin Cancelled under Section 30(1)(c) of the Act

10 October 2018

Cancellation by sponsor

Requested by Melrose Laboratories Pty Ltd
Melrose Vitamins K2 + D3 Cancelled under Section 30(1)(c) of the Act

10 October 2018

Cancellation by sponsor

Requested by Melrose Laboratories Pty Ltd
Bio-Curcumin Cancelled under Section 30(1)(c) of the Act

10 October 2018

Cancellation by sponsor

Requested by Melrose Laboratories Pty Ltd
Cranberry plus Probiotics Cancelled under Section 30(1)(c) of the Act

10 October 2018

Cancellation by sponsor

Requested by Melrose Laboratories Pty Ltd
OLBAS Pastiles Cancelled under Section 30(1)(c) of the Act

10 October 2018

Cancellation by sponsor

Requested by Melrose Laboratories Pty Ltd
Melrose Olive Leaf Extract Natural Flavour (Cancelled from the ARTG under subsection 30(2)(e) of the Act)

5 July 2018

Cancellation or suspension

Regulatory action due to The goods do not conform to a standard applicable to the goods., effective 05/07/2018
Clarity Decongesting Rub Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Melrose Laboratories Pty Ltd
Clarity Decongesting Inhaler Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Melrose Laboratories Pty Ltd
Melrose Premium Omega 18/12 Fish Oil 1000 mg capsules Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Melrose Laboratories Pty Ltd
High Strength Fish Oil + Vitamin D Capsules Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Melrose Laboratories Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.